Yellow Card Scheme is the UK system
The Yellow Card Scheme is the UK system for collecting information on suspected adverse drug reactions (ADRs) to medicines. The scheme allows the safety of the medicines and vaccines that are on the market to be monitored. The Scheme was founded in 1964 after the thalidomide disaster, and was developed by Bill Inman.
The Yellow Card Scheme is the UK system for collecting and monitoring information on suspected safety concerns or incidents involving medicines and medical devices. The Scheme is run by the MHRA and currently relies on voluntary reporting of suspected ADRs by health professionals and patients. The purpose of the Scheme is to provide an early warning that the safety of a product may require further investigation.
For more information: https://yellowcard.mhra.gov.uk/